Comparison of hyperglycemia risk between short- (≤7 days) and long- (>7 days) duration regimens of corticosteroids.

Comparison of the treatment side effects among sodium valproate and dexamethasone groups 2 hours post-treatment.

Shahir Mazaheri (707108)
Jalal Poorolajal (295323)
Akram Hosseinzadeh (707109)
Mohammad Mahdi Fazlian (707110)

March 2015

Comparison of the treatment side effects among sodium valproate and dexamethasone groups 2 hours ...

Sensitivity analysis with non-imputed NEWS2 data showing effect of dexamethasone on mortality at day 28.

Michael R. Ardern-Jones (14439496)
Hang T. T. Phan (10013171)
Florina Borca (10013198)
Matt Stammers (10013162)
James Batchelor (10013201)
Isabel C. Reading (14439499)
Sophie V. Fletcher (14439502)
Trevor Smith (5728859)
Andrew S. Duncombe (14439505)

January 2023

(a) Kaplan–Meier survival curves for 28-day mortality among the whole cohort in those who were treat...

Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration

BRICNOLA C.
DE SIMONE G.
BELLOLI C.
IANNONE P.
BELLUZZI A.
GIONCHETTI P.
CAMPIERI M.
BARBARA L.

January 1994

Background: Steroids are highly effective in active Crohn's disease; clinical relapse following ster...

Comparison of hyperglycemia risk between short- (≤7 days) and long- (>7 days) duration regimens of corticosteroids.

Zhen Zhao (159931)
Owen Lou (17712023)
Yiyang Wang (291591)
Raymond Yin (16914084)
Carrie Gong (17712026)
Florence Deng (17712029)
Ethan C. Wu (17712032)
Jing Yi Xie (17712035)
Jerry Wu (2997408)
Avery Ma (17712038)
Yongzhi Guo (295416)
Wei Ting Xiong (17712041)

December 2023

Comparison of hyperglycemia risk between short- (≤7 days) and long- (>7 days) duration regimens of c...

Comparison of mortality risk between short- (≤7 days) and long- (>7 days) duration regimens of corticosteroids.

Zhen Zhao (159931)
Owen Lou (17712023)
Yiyang Wang (291591)
Raymond Yin (16914084)
Carrie Gong (17712026)
Florence Deng (17712029)
Ethan C. Wu (17712032)
Jing Yi Xie (17712035)
Jerry Wu (2997408)
Avery Ma (17712038)
Yongzhi Guo (295416)
Wei Ting Xiong (17712041)

December 2023

Comparison of mortality risk between short- (≤7 days) and long- (>7 days) duration regimens of corti...

Comparison of re-exacerbation risk between short- (≤7 days) and long- (>7 days) duration regimens of corticosteroids.

Zhen Zhao (159931)
Owen Lou (17712023)
Yiyang Wang (291591)
Raymond Yin (16914084)
Carrie Gong (17712026)
Florence Deng (17712029)
Ethan C. Wu (17712032)
Jing Yi Xie (17712035)
Jerry Wu (2997408)
Avery Ma (17712038)
Yongzhi Guo (295416)
Wei Ting Xiong (17712041)

December 2023

Comparison of re-exacerbation risk between short- (≤7 days) and long- (>7 days) duration regimens of...

Comparison of hospital length-of-stay between short- (≤7 days) and long- (>7 days) duration regimens of corticosteroids.

Zhen Zhao (159931)
Owen Lou (17712023)
Yiyang Wang (291591)
Raymond Yin (16914084)
Carrie Gong (17712026)
Florence Deng (17712029)
Ethan C. Wu (17712032)
Jing Yi Xie (17712035)
Jerry Wu (2997408)
Avery Ma (17712038)
Yongzhi Guo (295416)
Wei Ting Xiong (17712041)

December 2023

Comparison of hospital length-of-stay between short- (≤7 days) and long- (>7 days) duration regimens...

Comparison of FEV1 change between short- (≤7 days) and long- (>7 days) duration regimens of corticosteroids.

Zhen Zhao (159931)
Owen Lou (17712023)
Yiyang Wang (291591)
Raymond Yin (16914084)
Carrie Gong (17712026)
Florence Deng (17712029)
Ethan C. Wu (17712032)
Jing Yi Xie (17712035)
Jerry Wu (2997408)
Avery Ma (17712038)
Yongzhi Guo (295416)
Wei Ting Xiong (17712041)

December 2023

Comparison of FEV1 change between short- (≤7 days) and long- (>7 days) duration regimens of corticos...

Comparison of blood glucose levels between NPH and premixed insulin regimens.

Ashenafi Kibret Sendekie (12646960)
Adeladlew Kassie Netere (4621486)
Eyayaw Ashete Belachew (13840796)

September 2022

Comparison of blood glucose levels between NPH and premixed insulin regimens.</p

Glucocorticoids and the risk for initiation of hypoglycemic therapy.

Gurwitz, Jerry H.
Bohn, Rhonda L.
Glynn, Robert J.
Monane, Mark
Mogun, Helen
Avorn, Jerry

January 1994

PURPOSE: To quantify risk for the occurrence of hyperglycemia requiring initiation of hypoglycemic t...

Comparison of corticosteroid dosing regimen used according to insulin regimen used.

Hasniza Zaman Huri (515149)
Vishaaliny Permalu (624630)
Shireene Ratna Vethakkan (624631)

September 2014

a Computed using Fisher's Exact Test.Comparison of corticosteroid dosing regimen used acco...

Comparison of the reduction in triglycerides with conservative treatment during 24-hour episodes without plasma exchange (PE) (conservative management, N = 29) and during PE treatments.

Jakob Gubensek (601923)
Jadranka Buturovic-Ponikvar (601924)
Karmen Romozi (601925)
Rafael Ponikvar (601926)

July 2014

Comparison of the reduction in triglycerides with conservative treatment during 24-hour episodes ...

Comparison between corticosterone levels on gestational days 11 and 17 in every group.

Zahra Jafari (4236712)
Jogender Mehla (4236724)
Navvab Afrashteh (4236715)
Bryan E. Kolb (4236721)
Majid H. Mohajerani (4236718)

July 2017

Comparison between corticosterone levels on gestational days 11 and 17 in every group.</p

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: Viewpoints from an EULAR task force

Strehl, C.
Bijlsma, J.W.J.
de Wit, M.
Boers, M.
Caeyers, N.
Cutolo, M.
Dasgupta, B.
Dixon, W.G.
Geenen, R.
Huizinga, T.W.J.
Kent, A.
Ladefoged De Thurah, A.
Listing, J.
Mariette, X.
Ray, D.W.
Scherer, H.U.
Seror, R.
Spies, C.M.
Tarp, S.
Wiek, D.
Winthrop, K.L.
Buttgereit, F.

January 2016

There is convincing evidence for the known and unambiguously accepted beneficial effects of glucocor...

What is the optimal time for measuring glucose concentration to detect steroid-induced hyperglycemia in patients with rheumatic diseases?

Cansu, Güven Barış
Cansu, Dondu Uskudar
Taskiran, BENGÜR
Bilge, Sule Yasar
Bilgin, Muzaffer
Korkmaz, Cengiz

May 2019

Objective: Corticosteroids may cause hyperglycemia and diabetes mellitus (DM). Development of DM dur...

Comparison of the treatment side effects among sodium valproate and dexamethasone groups 2 hours post-treatment.

Shahir Mazaheri (707108)
Jalal Poorolajal (295323)
Akram Hosseinzadeh (707109)
Mohammad Mahdi Fazlian (707110)

March 2015

Comparison of the treatment side effects among sodium valproate and dexamethasone groups 2 hours ...

Sensitivity analysis with non-imputed NEWS2 data showing effect of dexamethasone on mortality at day 28.

Michael R. Ardern-Jones (14439496)
Hang T. T. Phan (10013171)
Florina Borca (10013198)
Matt Stammers (10013162)
James Batchelor (10013201)
Isabel C. Reading (14439499)
Sophie V. Fletcher (14439502)
Trevor Smith (5728859)
Andrew S. Duncombe (14439505)

January 2023

(a) Kaplan–Meier survival curves for 28-day mortality among the whole cohort in those who were treat...

Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration

BRICNOLA C.
DE SIMONE G.
BELLOLI C.
IANNONE P.
BELLUZZI A.
GIONCHETTI P.
CAMPIERI M.
BARBARA L.

January 1994

Background: Steroids are highly effective in active Crohn's disease; clinical relapse following ster...

Comparison of hyperglycemia risk between short- (≤7 days) and long- (>7 days) duration regimens of corticosteroids.

Zhen Zhao (159931)
Owen Lou (17712023)
Yiyang Wang (291591)
Raymond Yin (16914084)
Carrie Gong (17712026)
Florence Deng (17712029)
Ethan C. Wu (17712032)
Jing Yi Xie (17712035)
Jerry Wu (2997408)
Avery Ma (17712038)
Yongzhi Guo (295416)
Wei Ting Xiong (17712041)

December 2023

Comparison of hyperglycemia risk between short- (≤7 days) and long- (>7 days) duration regimens of c...

Comparison of mortality risk between short- (≤7 days) and long- (>7 days) duration regimens of corticosteroids.

Zhen Zhao (159931)
Owen Lou (17712023)
Yiyang Wang (291591)
Raymond Yin (16914084)
Carrie Gong (17712026)
Florence Deng (17712029)
Ethan C. Wu (17712032)
Jing Yi Xie (17712035)
Jerry Wu (2997408)
Avery Ma (17712038)
Yongzhi Guo (295416)
Wei Ting Xiong (17712041)

December 2023

Comparison of mortality risk between short- (≤7 days) and long- (>7 days) duration regimens of corti...

Comparison of re-exacerbation risk between short- (≤7 days) and long- (>7 days) duration regimens of corticosteroids.

Zhen Zhao (159931)
Owen Lou (17712023)
Yiyang Wang (291591)
Raymond Yin (16914084)
Carrie Gong (17712026)
Florence Deng (17712029)
Ethan C. Wu (17712032)
Jing Yi Xie (17712035)
Jerry Wu (2997408)
Avery Ma (17712038)
Yongzhi Guo (295416)
Wei Ting Xiong (17712041)

December 2023

Comparison of re-exacerbation risk between short- (≤7 days) and long- (>7 days) duration regimens of...

Comparison of hospital length-of-stay between short- (≤7 days) and long- (>7 days) duration regimens of corticosteroids.

Zhen Zhao (159931)
Owen Lou (17712023)
Yiyang Wang (291591)
Raymond Yin (16914084)
Carrie Gong (17712026)
Florence Deng (17712029)
Ethan C. Wu (17712032)
Jing Yi Xie (17712035)
Jerry Wu (2997408)
Avery Ma (17712038)
Yongzhi Guo (295416)
Wei Ting Xiong (17712041)

December 2023

Comparison of hospital length-of-stay between short- (≤7 days) and long- (>7 days) duration regimens...

Comparison of FEV1 change between short- (≤7 days) and long- (>7 days) duration regimens of corticosteroids.

Zhen Zhao (159931)
Owen Lou (17712023)
Yiyang Wang (291591)
Raymond Yin (16914084)
Carrie Gong (17712026)
Florence Deng (17712029)
Ethan C. Wu (17712032)
Jing Yi Xie (17712035)
Jerry Wu (2997408)
Avery Ma (17712038)
Yongzhi Guo (295416)
Wei Ting Xiong (17712041)

December 2023

Comparison of FEV1 change between short- (≤7 days) and long- (>7 days) duration regimens of corticos...

Comparison of blood glucose levels between NPH and premixed insulin regimens.

Ashenafi Kibret Sendekie (12646960)
Adeladlew Kassie Netere (4621486)
Eyayaw Ashete Belachew (13840796)

September 2022

Comparison of blood glucose levels between NPH and premixed insulin regimens.</p

Glucocorticoids and the risk for initiation of hypoglycemic therapy.

Gurwitz, Jerry H.
Bohn, Rhonda L.
Glynn, Robert J.
Monane, Mark
Mogun, Helen
Avorn, Jerry

January 1994

PURPOSE: To quantify risk for the occurrence of hyperglycemia requiring initiation of hypoglycemic t...

Comparison of corticosteroid dosing regimen used according to insulin regimen used.

Hasniza Zaman Huri (515149)
Vishaaliny Permalu (624630)
Shireene Ratna Vethakkan (624631)

September 2014

a Computed using Fisher's Exact Test.Comparison of corticosteroid dosing regimen used acco...

Comparison of the reduction in triglycerides with conservative treatment during 24-hour episodes without plasma exchange (PE) (conservative management, N = 29) and during PE treatments.

Jakob Gubensek (601923)
Jadranka Buturovic-Ponikvar (601924)
Karmen Romozi (601925)
Rafael Ponikvar (601926)

July 2014

Comparison of the reduction in triglycerides with conservative treatment during 24-hour episodes ...

Comparison between corticosterone levels on gestational days 11 and 17 in every group.

Zahra Jafari (4236712)
Jogender Mehla (4236724)
Navvab Afrashteh (4236715)
Bryan E. Kolb (4236721)
Majid H. Mohajerani (4236718)

July 2017

Comparison between corticosterone levels on gestational days 11 and 17 in every group.</p

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: Viewpoints from an EULAR task force

Strehl, C.
Bijlsma, J.W.J.
de Wit, M.
Boers, M.
Caeyers, N.
Cutolo, M.
Dasgupta, B.
Dixon, W.G.
Geenen, R.
Huizinga, T.W.J.
Kent, A.
Ladefoged De Thurah, A.
Listing, J.
Mariette, X.
Ray, D.W.
Scherer, H.U.
Seror, R.
Spies, C.M.
Tarp, S.
Wiek, D.
Winthrop, K.L.
Buttgereit, F.

January 2016

There is convincing evidence for the known and unambiguously accepted beneficial effects of glucocor...

What is the optimal time for measuring glucose concentration to detect steroid-induced hyperglycemia in patients with rheumatic diseases?

Cansu, Güven Barış
Cansu, Dondu Uskudar
Taskiran, BENGÜR
Bilge, Sule Yasar
Bilgin, Muzaffer
Korkmaz, Cengiz

May 2019

Objective: Corticosteroids may cause hyperglycemia and diabetes mellitus (DM). Development of DM dur...

Comparison of the treatment side effects among sodium valproate and dexamethasone groups 2 hours post-treatment.

Shahir Mazaheri (707108)
Jalal Poorolajal (295323)
Akram Hosseinzadeh (707109)
Mohammad Mahdi Fazlian (707110)

March 2015

Comparison of the treatment side effects among sodium valproate and dexamethasone groups 2 hours ...

Sensitivity analysis with non-imputed NEWS2 data showing effect of dexamethasone on mortality at day 28.

Michael R. Ardern-Jones (14439496)
Hang T. T. Phan (10013171)
Florina Borca (10013198)
Matt Stammers (10013162)
James Batchelor (10013201)
Isabel C. Reading (14439499)
Sophie V. Fletcher (14439502)
Trevor Smith (5728859)
Andrew S. Duncombe (14439505)

January 2023

(a) Kaplan–Meier survival curves for 28-day mortality among the whole cohort in those who were treat...

Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration

BRICNOLA C.
DE SIMONE G.
BELLOLI C.
IANNONE P.
BELLUZZI A.
GIONCHETTI P.
CAMPIERI M.
BARBARA L.

January 1994

Background: Steroids are highly effective in active Crohn's disease; clinical relapse following ster...

Comparison of hyperglycemia risk between short- (≤7 days) and long- (>7 days) duration regimens of corticosteroids.

Abstract

Extracted data

Comparison of hyperglycemia risk between short- (≤7 days) and long- (>7 days) duration regimens of corticosteroids.

Abstract

Extracted data

Related items

Related items